|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2004-4-8
|
|
pubmed:abstractText |
Treatment of secondary hyperparathyroidism with vitamin D and calcium in patients receiving dialysis is often complicated by hypercalcemia and hyperphosphatemia, which may contribute to cardiovascular disease and adverse clinical outcomes. Calcimimetics target the calcium-sensing receptor and lower parathyroid hormone levels without increasing calcium and phosphorus levels. We report the results of two identical randomized, double-blind, placebo-controlled trials evaluating the safety and effectiveness of the calcimimetic agent cinacalcet hydrochloride.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:Abu-AlfaAli KAK,
pubmed-author:AvramMorrell MMM,
pubmed-author:BlockGeoffrey AGA,
pubmed-author:BraunJohannJ,
pubmed-author:CohenRaphael MRM,
pubmed-author:CoyneDaniel WDW,
pubmed-author:CunninghamJohnJ,
pubmed-author:DrüekeTilman BTB,
pubmed-author:EvenepoelPieterP,
pubmed-author:FournierAlbertA,
pubmed-author:GoodmanWilliam GWG,
pubmed-author:HerczGavrilG,
pubmed-author:LocatelliFrancescoF,
pubmed-author:MartinKevin JKJ,
pubmed-author:McCaryLaura CLC,
pubmed-author:MessaPiergiorgioP,
pubmed-author:MoeSharon MSM,
pubmed-author:OlsonKurt AKA,
pubmed-author:SuranyiMichael GMG,
pubmed-author:TurnerStewart ASA,
pubmed-author:ZaniValter JVJ,
pubmed-author:de FranciscoAngel L MAL
|
|
pubmed:copyrightInfo |
Copyright 2004 Massachusetts Medical Society
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
8
|
|
pubmed:volume |
350
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1516-25
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15071126-Calcium,
pubmed-meshheading:15071126-Double-Blind Method,
pubmed-meshheading:15071126-Female,
pubmed-meshheading:15071126-Humans,
pubmed-meshheading:15071126-Hyperparathyroidism, Secondary,
pubmed-meshheading:15071126-Kidney Failure, Chronic,
pubmed-meshheading:15071126-Logistic Models,
pubmed-meshheading:15071126-Male,
pubmed-meshheading:15071126-Middle Aged,
pubmed-meshheading:15071126-Naphthalenes,
pubmed-meshheading:15071126-Parathyroid Hormone,
pubmed-meshheading:15071126-Phosphorus,
pubmed-meshheading:15071126-Renal Dialysis
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
|
|
pubmed:affiliation |
Denver Nephrologists, Denver, USA. gablock@denverneph.net
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
